A Human Atrial Natriuretic Peptide Gene Mutation Reveals a Novel Peptide With Enhanced Blood Pressure-Lowering, Renal-Enhancing, and Aldosterone-Suppressing Actions
- 8 September 2009
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 54 (11), 1024-1032
- https://doi.org/10.1016/j.jacc.2009.04.080
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Atrial Natriuretic Peptide Frameshift Mutation in Familial Atrial FibrillationThe New England Journal of Medicine, 2008
- Design, Synthesis, and Actions of a Novel Chimeric Natriuretic Peptide: CD-NPJournal of the American College of Cardiology, 2008
- Natriuretic Peptide Precursor A Gene Polymorphisms and Risk of Blood Pressure Progression and Incident HypertensionHypertension, 2007
- Enhanced activation of pro-inflammatory cytokines in mice lacking natriuretic peptide receptor-APeptides, 2007
- Effects of Pressure Overload on Extracellular Matrix Expression in the Heart of the Atrial Natriuretic Peptide–Null MouseHypertension, 2003
- The role of the C‐terminal region of rat brain natriuretic peptide in receptor selectivityFEBS Letters, 1992
- Role of endopeptidase‐24.11 in the inactivation of atrial natriuretic peptideFEBS Letters, 1988
- Physiologic and Pharmacologic Studies of Atrial Natriuretic Factor: A Natriuretic and Vasoactive PeptideThe Journal of Clinical Pharmacology, 1987
- Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.JCI Insight, 1986
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981